缬沙坦-话题@MedSci

#缬沙坦#

58篇内容 | 1589人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1367667, encodeId=dd6d136e66718, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=Circ-Heart Fail：心衰患者服用Sacubitril/缬沙坦的情况分析！, objectType=article, longId=130211, objectId=74f71302115f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74f71302115f, replyNumber=0, likeNumber=48, createdTime=2018-02-22, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74f71302115f, moduleTitle=Circ-Heart Fail：心衰患者服用Sacubitril/缬沙坦的情况分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74f71302115f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367666, encodeId=a895136e66670, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=诺华心衰新药沙库巴曲缬沙坦钠片首张处方产生, objectType=article, longId=113448, objectId=2ab3113448b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ab3113448b8, replyNumber=0, likeNumber=45, createdTime=2017-09-22, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ab3113448b8, moduleTitle=诺华心衰新药沙库巴曲缬沙坦钠片首张处方产生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ab3113448b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367665, encodeId=b809136e66512, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=Diabetes Obes Metab：缬沙坦能降低糖耐量降低患者的微量白蛋白尿发生率, objectType=article, longId=104091, objectId=01f81040916c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01f81040916c, replyNumber=0, likeNumber=31, createdTime=2017-07-01, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01f81040916c, moduleTitle=Diabetes Obes Metab：缬沙坦能降低糖耐量降低患者的微量白蛋白尿发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01f81040916c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367664, encodeId=6ef1136e6646a, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=Transplantation：缬沙坦通过改善肾klotho表达和氧化性应激减缓环孢素性肾中毒, objectType=article, longId=103671, objectId=7abc1036e19c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7abc1036e19c, replyNumber=0, likeNumber=41, createdTime=2017-06-29, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7abc1036e19c, moduleTitle=Transplantation：缬沙坦通过改善肾klotho表达和氧化性应激减缓环孢素性肾中毒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7abc1036e19c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367663, encodeId=8398136e66342, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=控制夜间高血压良方：夜间加用缬沙坦效果佳, objectType=article, longId=100979, objectId=fb521009e914, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb521009e914, replyNumber=0, likeNumber=32, createdTime=2017-06-09, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb521009e914, moduleTitle=控制夜间高血压良方：夜间加用缬沙坦效果佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb521009e914)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367662, encodeId=56e0136e6620b, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=参芪地黄汤联合缬沙坦治疗气阴两虚型早期糖尿病肾病的临床疗效, objectType=article, longId=93903, objectId=614993903b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=614993903b2, replyNumber=0, likeNumber=35, createdTime=2017-03-31, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=614993903b2, moduleTitle=参芪地黄汤联合缬沙坦治疗气阴两虚型早期糖尿病肾病的临床疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=614993903b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367661, encodeId=85a7136e66160, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=Hypertension：老年收缩期高血压患者sacubitril /缬沙坦与奥美沙坦疗效比较, objectType=article, longId=87851, objectId=21f08e851a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21f08e851a8, replyNumber=0, likeNumber=33, createdTime=2017-01-21, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21f08e851a8, moduleTitle=Hypertension：老年收缩期高血压患者sacubitril /缬沙坦与奥美沙坦疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21f08e851a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367660, encodeId=e57d136e660cd, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=JACC：Sacubitril/缬沙坦可减少HF患者的再入院率, objectType=article, longId=72772, objectId=9a2ae277276, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a2ae277276, replyNumber=0, likeNumber=34, createdTime=2016-07-15, rootId=0, userName=medscijoin, userId=f73a255, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a2ae277276, moduleTitle=JACC：Sacubitril/缬沙坦可减少HF患者的再入院率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a2ae277276)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367659, encodeId=c1b7136e659b8, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=艾尔健抗高血压药物Byvalson（奈必洛尔/缬沙坦复方）喜获FDA批准, objectType=article, longId=70374, objectId=1534e037459, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1534e037459, replyNumber=0, likeNumber=35, createdTime=2016-06-11, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1534e037459, moduleTitle=艾尔健抗高血压药物Byvalson（奈必洛尔/缬沙坦复方）喜获FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1534e037459)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367658, encodeId=9544136e65899, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=FDA拒绝批准奈比洛尔/缬沙坦组合治疗高血压, objectType=article, longId=44981, objectId=dc3f44981f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc3f44981f9, replyNumber=0, likeNumber=33, createdTime=2015-01-06, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc3f44981f9, moduleTitle=FDA拒绝批准奈比洛尔/缬沙坦组合治疗高血压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc3f44981f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367657, encodeId=bf7e136e657c3, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=FDA拒批阿特维斯奈必洛尔、缬沙坦复方药, objectType=article, longId=44768, objectId=f6df44e6898, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6df44e6898, replyNumber=0, likeNumber=25, createdTime=2014-12-31, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6df44e6898, moduleTitle=FDA拒批阿特维斯奈必洛尔、缬沙坦复方药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6df44e6898)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367656, encodeId=b9d7136e656e7, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=Diabetes：普伐他汀和缬沙坦联合治疗高胆固醇血症效果优于单药治疗, objectType=article, longId=21967, objectId=f17a2196e90, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f17a2196e90, replyNumber=0, likeNumber=39, createdTime=2013-07-26, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f17a2196e90, moduleTitle=Diabetes：普伐他汀和缬沙坦联合治疗高胆固醇血症效果优于单药治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f17a2196e90)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367655, encodeId=43a3136e65537, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=CMAJ：糖尿病患者使用替米沙坦和缬沙坦并发心血管疾病风险较低, objectType=article, longId=21601, objectId=f6de216015d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6de216015d, replyNumber=0, likeNumber=41, createdTime=2013-07-20, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6de216015d, moduleTitle=CMAJ：糖尿病患者使用替米沙坦和缬沙坦并发心血管疾病风险较低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6de216015d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367654, encodeId=c68d136e65439, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=JCEM: 缬沙坦改善脂肪组织脂质缓冲能力, objectType=article, longId=16971, objectId=ac80169e13c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac80169e13c, replyNumber=0, likeNumber=36, createdTime=2013-04-11, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac80169e13c, moduleTitle=JCEM: 缬沙坦改善脂肪组织脂质缓冲能力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac80169e13c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367653, encodeId=265e136e6534a, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=KYOTO HEART研究：缬沙坦对伴CKD高血压者有益, objectType=article, longId=3062, objectId=ca8f3062c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca8f3062c2, replyNumber=0, likeNumber=43, createdTime=2011-09-08, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca8f3062c2, moduleTitle=KYOTO HEART研究：缬沙坦对伴CKD高血压者有益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca8f3062c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367652, encodeId=f055136e652fe, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=缬沙坦再添亚洲人群心脑血管保护新证据, objectType=article, longId=2120, objectId=70072120d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70072120d6, replyNumber=0, likeNumber=30, createdTime=2010-09-11, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70072120d6, moduleTitle=缬沙坦再添亚洲人群心脑血管保护新证据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70072120d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367651, encodeId=83c4136e651e9, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=KYOTO HEART 研究：高危高血压患者应用缬沙坦对心血管事件的影响：KYOTO HEART 研究的全新分析, objectType=article, longId=2114, objectId=755321140e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=755321140e, replyNumber=0, likeNumber=34, createdTime=2010-09-11, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=755321140e, moduleTitle=KYOTO HEART 研究：高危高血压患者应用缬沙坦对心血管事件的影响：KYOTO HEART 研究的全新分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=755321140e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1367650, encodeId=01e2136e650d5, content=<a href='/topic/show?id=9334e9305c7' target=_blank style='color:#2F92EE;'>#缬沙坦#</a>, objectTitle=JIKEI HEART：在日本缬沙坦对冠状动脉疾病患者的作用, objectType=article, longId=2113, objectId=ede121132c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ede121132c, replyNumber=0, likeNumber=44, createdTime=2010-09-11, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ede121132c, moduleTitle=JIKEI HEART：在日本缬沙坦对冠状动脉疾病患者的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ede121132c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

缬沙坦

2020-05-29

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

Circ-Heart Fail：心衰患者服用Sacubitril/缬沙坦的情况分析！

2018-02-22

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

诺华心衰新药沙库巴曲缬沙坦钠片首张处方产生

2017-09-22

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

Diabetes Obes Metab：缬沙坦能降低糖耐量降低患者的微量白蛋白尿发生率

2017-07-01

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

Transplantation：缬沙坦通过改善肾klotho表达和氧化性应激减缓环孢素性肾中毒

2017-06-29

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

控制夜间高血压良方：夜间加用缬沙坦效果佳

2017-06-09

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

参芪地黄汤联合缬沙坦治疗气阴两虚型早期糖尿病肾病的临床疗效

2017-03-31

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

Hypertension：老年收缩期高血压患者sacubitril /缬沙坦与奥美沙坦疗效比较

2017-01-21

medscijoin (审核中...)

前往app查看评论内容

#缬沙坦#

JACC：Sacubitril/缬沙坦可减少HF患者的再入院率

2016-07-15

柳叶一刀 (审核中...)

前往app查看评论内容

#缬沙坦#

艾尔健抗高血压药物Byvalson（奈必洛尔/缬沙坦复方）喜获FDA批准

2016-06-11

柳叶一刀 (审核中...)

前往app查看评论内容

#缬沙坦#

FDA拒绝批准奈比洛尔/缬沙坦组合治疗高血压

2015-01-06

柳叶一刀 (审核中...)

前往app查看评论内容

#缬沙坦#

FDA拒批阿特维斯奈必洛尔、缬沙坦复方药

2014-12-31

柳叶一刀 (审核中...)

前往app查看评论内容

#缬沙坦#

Diabetes：普伐他汀和缬沙坦联合治疗高胆固醇血症效果优于单药治疗

2013-07-26

柳叶一刀 (审核中...)

前往app查看评论内容

#缬沙坦#

CMAJ：糖尿病患者使用替米沙坦和缬沙坦并发心血管疾病风险较低

2013-07-20

柳叶一刀 (审核中...)

前往app查看评论内容

#缬沙坦#

JCEM: 缬沙坦改善脂肪组织脂质缓冲能力

2013-04-11

柳叶一刀 (审核中...)

前往app查看评论内容

#缬沙坦#

KYOTO HEART研究：缬沙坦对伴CKD高血压者有益

2011-09-08

柳叶一刀 (审核中...)

前往app查看评论内容

#缬沙坦#

缬沙坦再添亚洲人群心脑血管保护新证据

2010-09-11

柳叶一刀 (审核中...)

前往app查看评论内容

#缬沙坦#

KYOTO HEART 研究：高危高血压患者应用缬沙坦对心血管事件的影响：KYOTO HEART 研究的全新分析

2010-09-11

柳叶一刀 (审核中...)

前往app查看评论内容

#缬沙坦#

JIKEI HEART：在日本缬沙坦对冠状动脉疾病患者的作用

2010-09-11

科室
- - 订阅+
  - 更多科室
工具
服务